Entity
Description
  • Value proposition

    European Patients' Academy on Therapeutic Innovation

    The European Patients’ Academy on Therapeutic Innovation (EUPATI) provides education and training for patients and patient representatives on the process of medicines research and development (R&D). The trained patient experts are key to realising meaningful patient engagement in medicines R&D, regulatory deliberations and other activities.

    EUPATI was established by the Innovative Medicines Initiative (IMI) in 2012, and was hosted by the European Patients’ Forum (EPF) as a Public-Private Partnership Programme 2017-2020.
    EUPATI is today established as an independent non-profit Foundation in the Netherlands and has 24 National Platforms in Europe and in Japan.

    “We focus on education and training to increase the capacity and capability of patients to be valuable contributors to medicines research and development by working with patients and the stakeholders they collaborate with.”

Corporate interactions BETA
Corporate TypeTweets Articles
Servier Pharmaceuticals
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Servier Pharmaceuticals
Pharmaceutical, Pharmaceutical Manufacturing
Other

17 Dec 2019


Bayer
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Bayer
Pharmaceutical, Chemistry, Chemical Manufacturing
Other

15 Dec 2021


Eurostat
Eurostat
European Union, Environmental Services
Eurostat
European Union, Environmental Services
Other

8 Oct 2019


Boehringer Ingelheim
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Boehringer Ingelheim
Pharmaceutical, Pharmaceutical Manufacturing, Animal Health
Other

16 Sep 2021


Similar entities
Loading...
Loading...
Social network dynamics